First Manhattan’s VanEck Biotech ETF BBH Stock Holding History

First Manhattan’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-150	Closed	-$24.9K	–	721
2024 Q1	$24.9K	Hold	150	–	–	﹤0.01%	999
2023 Q4	$24.8K	Hold	150	–	–	﹤0.01%	990
2023 Q3	$23.4K	Hold	150	–	–	﹤0.01%	1001
2023 Q2	$23.4K	Sell	150 -50	-25%	-$7.99K	﹤0.01%	1006
2023 Q1	$32.4K	Hold	200	–	–	﹤0.01%	1000
2022 Q4	$31.9K	Hold	200	–	–	﹤0.01%	1017
2022 Q3	$28K	Hold	200	–	–	﹤0.01%	1035
2022 Q2	$29K	Hold	200	–	–	﹤0.01%	1058
2022 Q1	$32K	Sell	200 -200	-50%	-$32.4K	﹤0.01%	1079
2021 Q4	$75K	Hold	400	–	–	﹤0.01%	916
2021 Q3	$80K	Hold	400	–	–	﹤0.01%	905
2021 Q2	$80K	Hold	400	–	–	﹤0.01%	892
2021 Q1	$70K	Hold	400	–	–	﹤0.01%	887
2020 Q4	$67K	Hold	400	–	–	﹤0.01%	854
2020 Q3	$64K	Hold	400	–	–	﹤0.01%	847
2020 Q2	$65K	Hold	400	–	–	﹤0.01%	829
2020 Q1	$51K	Buy	400 +200	+100%	+$26.9K	﹤0.01%	847
2019 Q4	$27K	Hold	200	–	–	﹤0.01%	989
2019 Q3	$23K	Sell	200 -2,150	-91%	-$267K	﹤0.01%	1029
2019 Q2	$303K	Buy	2,350 +200	+9%	+$24.7K	﹤0.01%	629
2019 Q1	$276K	Hold	2,150	–	–	﹤0.01%	650
2018 Q4	$238K	Hold	2,150	–	–	﹤0.01%	661
2018 Q3	$292K	Sell	2,150 -850	-28%	-$111K	﹤0.01%	661
2018 Q2	$359K	Hold	3,000	–	–	﹤0.01%	598
2018 Q1	$361K	Hold	3,000	–	–	﹤0.01%	583
2017 Q4	$373K	Hold	3,000	–	–	﹤0.01%	589
2017 Q3	$402K	Hold	3,000	–	–	﹤0.01%	565
2017 Q2	$376K	Hold	3,000	–	–	﹤0.01%	567
2017 Q1	$357K	Hold	3,000	–	–	﹤0.01%	578
2016 Q4	$322K	Hold	3,000	–	–	﹤0.01%	579
2016 Q3	$345K	Hold	3,000	–	–	﹤0.01%	568
2016 Q2	$307K	Hold	3,000	–	–	﹤0.01%	594
2016 Q1	$311K	Hold	3,000	–	–	﹤0.01%	583
2015 Q4	$380K	Hold	3,000	–	–	﹤0.01%	551
2015 Q3	$342K	Hold	3,000	–	–	﹤0.01%	572
2015 Q2	$404K	Hold	3,000	–	–	﹤0.01%	559
2015 Q1	$388K	Hold	3,000	–	–	﹤0.01%	562
2014 Q4	$346K	Hold	3,000	–	–	﹤0.01%	592
2014 Q3	$317K	Hold	3,000	–	–	﹤0.01%	604
2014 Q2	$286K	Hold	3,000	–	–	﹤0.01%	621
2014 Q1	$272K	Hold	3,000	–	–	﹤0.01%	628
2013 Q4	$265K	Hold	3,000	–	–	﹤0.01%	623
2013 Q3	$248K	Hold	3,000	–	–	﹤0.01%	627
2013 Q2	$233K	Buy	+3,000	New	+$209K	﹤0.01%	637

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

First Manhattan's BBH Position: Q2 2024 in Review

First Manhattan sold out of VanEck Biotech ETF (BBH) in Q2 2024, closing a stake of 150 shares — an estimated $24.9K sold.

First Manhattan first reported a position in BBH in Q2 2013 and held it in 44 quarters. The position peaked at $404K in Q2 2015. 116 funds tracked by Wall St. Rank hold BBH as of Q2 2024.

First Manhattan reported no remaining VanEck Biotech ETF position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 150 VanEck Biotech ETF shares in Q2 2024, an estimated $24.9K.
First Manhattan first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 44 quarters.
First Manhattan's VanEck Biotech ETF position peaked at $404K in Q2 2015.
116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.